Ivermectin dosing for children under 2 years
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Wenyu Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fudan University, No. 826, Zhangheng Road, Pudong New Area, Shanghai, China. Hauptthemen laut MEDLINE: Ivermectin, Antiparasitic Agents, Scabies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
Ivermectin is effective against scabies but not licensed for children weighing <15 kg. We aimed to identify an ivermectin dosing strategy for children aged <2 years.
Methods
Doses for three age subgroups under 2 years were simulated by incorporating a maturation function for metabolizing enzymes into a population pharmacokinetic (PopPK) model to achieve median plasma AUC0–∞ between 80% and 125% of that observed in children aged 5–15 years receiving the standard 200 μg/kg dose (AUC0–∞ 976 μg/L h). Patient covariates were sampled from the National Health and Nutrition Examination Survey dataset. Final doses were rounded to feasible fractions of a 3 mg tablet.
Results
For infants aged 3–7 months, a 0.75 mg dose (one-fourth tablet) resulted in a median AUC0–∞ of 835 μg/L h [IQR: 632–1017]; for 8–12 months, a 1.5 mg dose (one-half tablet) yielded 848 μg/L h [IQR: 774–934]; and for 13–24 months, a 3 mg dose (one tablet) resulted in 1033 μg/L h [IQR: 943–1173]. All doses achieved median exposures within 80%–125% of the reference AUC in older children.
Conclusions
A dosing strategy for ivermectin in children aged 3 months–2 years was developed using a CYP3A4 maturation-based PopPK model. This regimen will be evaluated in an upcoming clinical trial to inform safe and effective scabies treatment in young children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fudan University, No. 826, Zhangheng Road, Pudong New Area, Shanghai, China.
- The Royal Children's Hospital Melbourne, 50 Flemington Rd, Parkville, Victoria, Australia.
- Murdoch Children's Research Institute, 50 Flemington Rd, Parkville, Victoria, Australia.
- Burnet Institute, Melbourne, Victoria, Australia.
- Lao Tropical and Public Health Institute, Ministry of Health, Samsenthai Road, Ban Koagnot, Sisattanack District, Vientiane Capital, Lao PDR.
- Department of Paediatrics, The University of Melbourne, 50 Flemington Rd, Parkville, Victoria, Australia.
ORCID-Profile: Xiao Zhu
Zitieren
APA
Yang, W., Steer, A., Coghlan, B., Phongluxa, K., Zhu, X., & Gwee, A. (2025). Ivermectin dosing for children under 2 years. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf344
Vancouver
Yang W, Steer A, Coghlan B, Phongluxa K, Zhu X, Gwee A. Ivermectin dosing for children under 2 years. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf344
BibTeX
@article{Yang2025,
author = {Yang, Wenyu and Steer, Andrew and Coghlan, Ben and Phongluxa, Khampheng and Zhu, Xiao and Gwee, Amanda},
title = {Ivermectin dosing for children under 2 years},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf344}
}
EUVIMED